Wellington Shields & Co., LLC Vertex Pharmaceuticals Inc Transaction History

Wellington Shields & Co., LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $187,968 - $234,040	-800 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$221.42 - $260.97 $44,284 - $52,194	-200 Reduced 20.0%	800 $209,000
Q4 2021 Feb 15, 2022	SELL	$177.01 - $223.45 $35,402 - $44,690	-200 Reduced 16.67%	1,000 $220,000
Q2 2021 Aug 12, 2021	BUY	$187.49 - $221.1 $224,988 - $265,320	1,200 New	1,200 $242,000

1,722

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Wellington Shields & Co., LLC, based on Form 13F filings with the SEC.

Stay updated on Wellington Shields & Co., LLC with notifications on news.